Pirfenidone treatment in individuals with idiopathic pulmonary fibrosis: Impact of timing of treatment initiation
File(s)PirfenidoneTreatmentInIndividuals.pdf (667.14 KB)
Published version
Author(s)
Type
Journal Article
Date Issued
2019-07-01
Date Acceptance
2019-04-03
ISSN
2329-6933
Publisher
American Thoracic Society
Start Page
927
End Page
930
Journal / Book Title
Annals of the American Thoracic Society
Volume
16
Issue
7
Copyright Statement
© 2019 by the American Thoracic Society. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/). For commercial usage and reprints please contact Diane Gern (dgern@thoracic.org).
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30950636
Subjects
Science & Technology
Life Sciences & Biomedicine
Respiratory System
NINTEDANIB
EFFICACY
Respiratory System
1103 Clinical Sciences
Publication Status
Published
Country
United States
Date Publish Online
2019-04-05